default author photo

John Waas

University of Pittsburgh - Medical Center (UPMC)

SCHOLARLY PAPERS

1

DOWNLOADS

87

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

A Phase II Clinical Trial Evaluating the Safety and Efficacy of Durvalumab as First Line Therapy in Advanced and Metastatic Non-Small Cell Lung Cancer Patients with Eastern Cooperative Oncology Group Performance Status of 2

Number of pages: 24 Posted: 07 Aug 2023
University of Pittsburgh - Medical Center (UPMC), University of Pittsburgh - Medical Center (UPMC), University of Pittsburgh - Medical Center (UPMC), University of Pittsburgh - Medical Center (UPMC), University of Pittsburgh - Medical Center (UPMC), University of Pittsburgh - Medical Center (UPMC), University of Pittsburgh - Medical Center (UPMC), University of Pittsburgh - Medical Center (UPMC), University of Pittsburgh - Medical Center (UPMC), University of Pittsburgh - Medical Center (UPMC), University of Texas at Dallas - Southwestern Medical Center, University of Texas at Dallas - Southwestern Medical Center and University of Pittsburgh - Medical Center (UPMC)
Downloads 87 (765,566)

Abstract:

Loading...

Durvalumab, non-small cell lung cancer, safety, overall survival, performance status 2